Honokiol is a FOXM1 antagonist
暂无分享,去创建一个
A. Gartel | J. Arbiser | M. Halasi | V. Gaponenko | E. Benevolenskaya | I. Khan | Binal N. Shah | B. Hitchinson | R. Váraljai
[1] R. Orlowski,et al. Proteasome inhibitors in cancer therapy , 2017, Nature Reviews Clinical Oncology.
[2] A. Gartel,et al. A Novel Function of Molecular Chaperone HSP70 , 2015, The Journal of Biological Chemistry.
[3] R. Chapple,et al. AMPK Protects Leukemia-Initiating Cells in Myeloid Leukemias from Metabolic Stress in the Bone Marrow. , 2015, Cell stem cell.
[4] J. Arbiser,et al. Honokiol activates LKB1-miR-34a axis and antagonizes the oncogenic actions of leptin in breast cancer , 2015, Oncotarget.
[5] Ash A. Alizadeh,et al. Abstract PR09: The prognostic landscape of genes and infiltrating immune cells across human cancers , 2015 .
[6] Dean P. Jones,et al. Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial SIRT3 , 2015, Nature Communications.
[7] Giovanni Marsico,et al. Small molecule inhibition of FOXM1: How to bring a novel compound into genomic context , 2014, Genomics data.
[8] M. Medvedovic,et al. SPDEF Inhibits Prostate Carcinogenesis by Disrupting a Positive Feedback Loop in Regulation of the Foxm1 Oncogene , 2014, PLoS genetics.
[9] J. Arbiser,et al. Honokiol inhibits androgen receptor activity in prostate cancer cells , 2014, The Prostate.
[10] A. Gartel,et al. ROS inhibitor N-acetyl-L-cysteine antagonizes the activity of proteasome inhibitors. , 2013, The Biochemical journal.
[11] S. Katiyar,et al. Honokiol Inhibits Non-Small Cell Lung Cancer Cell Migration by Targeting PGE2-Mediated Activation of β-Catenin Signaling , 2013, PloS one.
[12] A. Gartel,et al. Targeting FOXM1 in cancer. , 2013, Biochemical pharmacology.
[13] A. Gartel,et al. FOX(M1) News—It Is Cancer , 2013, Molecular Cancer Therapeutics.
[14] B. Fuchs,et al. Antimetastatic activity of honokiol in osteosarcoma , 2012, Cancer.
[15] A. Gartel,et al. The suppression of FOXM1 and its targets in breast cancer xenograft tumors by siRNA , 2011, Oncotarget.
[16] S. Arora,et al. Honokiol Arrests Cell Cycle, Induces Apoptosis, and Potentiates the Cytotoxic Effect of Gemcitabine in Human Pancreatic Cancer Cells , 2011, PloS one.
[17] William F. Richter,et al. Genome-wide Analysis using ChIP to Identify Isoform-specific Gene Targets , 2010, Journal of visualized experiments : JoVE.
[18] A. Gartel,et al. FoxM1 Is a General Target for Proteasome Inhibitors , 2009, PloS one.
[19] A. Gartel,et al. A novel mode of FoxM1 regulation: Positive auto-regulatory loop , 2009, Cell cycle.
[20] A. Gartel,et al. Thiazole Antibiotics Target FoxM1 and Induce Apoptosis in Human Cancer Cells , 2009, PloS one.
[21] D. Bar-Sagi,et al. Honokiol Suppresses Survival Signals Mediated by Ras-Dependent Phospholipase D Activity in Human Cancer Cells , 2008, Clinical Cancer Research.
[22] Lily Yang,et al. Shb gene knockdown increases the susceptibility of SVR endothelial tumor cells to apoptotic stimuli in vitro and in vivo. , 2008, The Journal of investigative dermatology.
[23] A. Gartel,et al. Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1. , 2006, Cancer research.
[24] B. Aggarwal,et al. Honokiol Potentiates Apoptosis, Suppresses Osteoclastogenesis, and Inhibits Invasion through Modulation of Nuclear Factor-κB Activation Pathway , 2006, Molecular Cancer Research.
[25] K. Anderson,et al. Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis. , 2004, Blood.
[26] J. Arbiser,et al. The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. , 2004, Blood.
[27] A. Datta,et al. Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. , 2004, Genes & development.
[28] Robert H. Costa,et al. Forkhead Box M1B Transcriptional Activity Requires Binding of Cdk-Cyclin Complexes for Phosphorylation-Dependent Recruitment of p300/CBP Coactivators , 2004, Molecular and Cellular Biology.
[29] P. M. Campbell,et al. Honokiol, a Small Molecular Weight Natural Product, Inhibits Angiogenesis in Vitro and Tumor Growth in Vivo* , 2003, Journal of Biological Chemistry.
[30] H. Itokawa,et al. [Studies on the components of Magnolia obovata Thunb. II. On the components of the methanol extract of the bark]. , 1973, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.
[31] Y. Oshika,et al. P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo. , 1996, British Journal of Cancer.